Similar articles for PMID: 33303517

Year	Number of Results
1967	2
1973	2
1975	1
1976	1
1978	1
1979	1
1982	1
1985	1
1987	1
1988	1
1989	3
1990	1
1991	2
1992	2
1993	2
1994	3
1995	1
1996	1
1997	3
1998	3
1999	2
2000	1
2001	1
2002	1
2003	3
2004	3
2005	2
2006	3
2007	1
2008	6
2010	1
2011	5
2013	1
2014	1
2015	4
2016	2
2020	20
2021	12
2022	1
2023	0

1

Lessons from a Pandemic: Maintaining Compliant GxP Surveillance Programs and Stable Pharmaceutical Supply.

Caraballo J, Fong F. Caraballo J, et al. PDA J Pharm Sci Technol. 2020 Nov-Dec;74(6):612-616. doi: 10.5731/pdajpst.2020.012518. PDA J Pharm Sci Technol. 2020. PMID: 33303517 No abstract available.

2

A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System.

Cocoros NM, Fuller CC, Adimadhyam S, Ball R, Brown JS, Dal Pan GJ, Kluberg SA, Lo Re V 3rd, Maro JC, Nguyen M, Orr R, Paraoan D, Perlin J, Poland RE, Driscoll MR, Sands K, Toh S, Yih WK, Platt R; And the FDA-Sentinel COVID-19 Working Group. Cocoros NM, et al. Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):827-837. doi: 10.1002/pds.5240. Epub 2021 Apr 18. Pharmacoepidemiol Drug Saf. 2021. PMID: 33797815 Free PMC article. Review.

3

Report suggests steps to improve safety of drug supply.

Traynor K. Traynor K. Am J Health Syst Pharm. 2011 Sep 1;68(17):1570, 1574. doi: 10.2146/news110060. Am J Health Syst Pharm. 2011. PMID: 21856799 No abstract available.

4

Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic.

Cundell T, Guilfoyle D, Kreil TR, Sawant A. Cundell T, et al. PDA J Pharm Sci Technol. 2020 Jul-Aug;74(4):468-494. doi: 10.5731/pdajpst.2020.012021. Epub 2020 May 28. PDA J Pharm Sci Technol. 2020. PMID: 32467176 Review.

5

COVID-vaccine results are on the way - and scientists' concerns are growing.

Mallapaty S, Ledford H. Mallapaty S, et al. Nature. 2020 Oct;586(7827):16-17. doi: 10.1038/d41586-020-02706-6. Nature. 2020. PMID: 32978611 No abstract available.

6

Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.

Avorn J, Kesselheim AS. Avorn J, et al. N Engl J Med. 2020 Oct 29;383(18):1706-1708. doi: 10.1056/NEJMp2029479. Epub 2020 Sep 15. N Engl J Med. 2020. PMID: 32931162 No abstract available.

7

Securing the US pharmaceutical supply.

Somberg JC. Somberg JC. Am J Ther. 2008 May-Jun;15(3):197. doi: 10.1097/MJT.0b013e31816fcddb. Am J Ther. 2008. PMID: 18496255 No abstract available.

8

Experts warn drug industry, government about weaknesses in drug supply chain.

Young D. Young D. Am J Health Syst Pharm. 2003 Nov 1;60(21):2176, 2180, 2184. doi: 10.1093/ajhp/60.21.2176. Am J Health Syst Pharm. 2003. PMID: 14619107 No abstract available.

9

Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic.

Robinson JC. Robinson JC. JAMA. 2021 Mar 2;325(9):825-826. doi: 10.1001/jama.2020.25384. JAMA. 2021. PMID: 33443546 No abstract available.

10

FDA embraces RFID to protect drug supply.

Young D. Young D. Am J Health Syst Pharm. 2004 Dec 15;61(24):2612, 2615. doi: 10.1093/ajhp/61.24.2612. Am J Health Syst Pharm. 2004. PMID: 15646694 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed